Open Access

Evolution of FXI(a) as a target for antithrombotic therapy

Congress Presentation

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
25 presentations
1 follower

5 more presentations in this session

Welcome and introduction

Speaker: Professor M. Sharma (Hamilton, CA)

Thumbnail

Epidemiology of stroke and disease burden

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)

Thumbnail

Uncovering the unmet need for patients: - with atrial fibrillation at risk of stroke - acute non-cardioembolic ischemic stroke or high-risk TIA

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE) Professor M. Sharma (Hamilton, CA)

Thumbnail

Outlining the clinical evidence landscape for FXI(a) inhibition: - stroke and bleeding prevention for patients with AF at risk of stroke - secondary stroke prevention in acute non-cardioembolic ischemic stroke or high-risk TIA

Speaker: Professor J. De Groot (Amsterdam, NL) Professor M. Sharma (Hamilton, CA)

Thumbnail

Q&A and closing remarks

Thumbnail

Access the full session

How can targeting FXI(a) advance antithrombotic therapy for stroke prevention?

Speakers: Doctor J. Weitz, Professor M. Sharma, Professor C. Blomstrom-Lundqvist, Professor C. Blomstrom-Lundqvist, Professor M. Sharma...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb